publication venue for
- ASSESSMENT OF PHARMACOKINETIC BAYESIAN PREDICTIONS IN HEMOPHILIA B USING LIMITED SAMPLING ANALYSIS. 2019
- EFFECTS OF ITRACONAZOLE ON THE PHARMACOKINETICS OF COPANLISIB, A NOVEL PAN-CLASS I PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR IN CANCER SUBJECTS. 2018
- METABOLOMIC AND GENOME-WIDE ASSOCIATION STUDIES REVEAL POTENTIAL ENDOGENOUS BIOMARKERS FOR OATP1B1 2017
- METFORMIN IS A SUBSTRATE AND INHIBITOR OF THE HUMAN INTESTINAL THIAMINE TRANSPORTER 2 (THTR-2; SLC19A3). 2016
- METFORMIN IS A SUBSTRATE AND INHIBITOR OF THE HUMAN INTESTINAL THIAMINE TRANSPORTER 2 (THTR-2; SLC19A3). 2016
- RISKS OF CONGENITAL MALFORMATIONS IN OFFSPRING EXPOSED TO VALPROIC ACID IN UTERO: A SYSTEMATIC REVIEW AND CUMULATIVE META-ANALYSIS. 2015
- DABIGATRAN PERSISTENCE IN THE COMMUNITY SETTING IN CANADA 2013
- SLCO1B1 521T > C GENOTYPE AFFECTS THE CYCLOSPORINE-PRAVASTATIN INTERACTION 2013
- A RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS SERUM TRANSAMINASE ELEVATIONS AND ANTIBODY FORMATION FOLLOWING REPEAT SUBCUTANEOUS DOSING OF LMWH, UFH OR THE NOVEL ANTICOAGULANT M118 IN HEALTHY VOLUNTEERS. 2011
- A REVIEW OF DUR METHODS REPORTED IN THE LITERATURE 2011
- N-ACETYLCYSTEINE AS A NOVEL PROPHYLACTIC TREATMENT FOR IFOSFAMIDE INDUCED NEPHROTOXICITY; TRANSLATIONAL PHARMACOKNETICS AND CASE REPORTS 2011
- CONCOMITANT USE OF CARDIOVASCULAR RELATED MEDICATIONS IN DIABETIC PATIENTS RECEIVING ROSIGLITAZONE. 2009
- Effect of a proton pump inhibitor therapeutic substitution policy in aboriginal patients in remote communities. 2008
- Assessing metabolic syndrome in patients using lipid lowering therapeutics in the Canadian population. 2007
- On the role of ABCB1 and ABCC2 in diaplacental transport of talinolol using the dually perfused human placenta model. 2007
- PIII-15Prioritizing treatment preferences in patients with type 2 diabetes 2006
- Impact of formulary policy on thiazolidinedione (TZD) use in the ontario drug benefit (ODB) program 2005
- Mixed or dynamic trial design: New methodology of research for pharmacogenetics and pharmacogenomics studies 2005
- Palatability of antiretroviral drugs in children with HIV: A survey of physician perceptions 2005
- Are brand-name and generic warfarin interchangeable? 2004
- Understanding Why Physicians Modify or Ignore Prescribing Guidelines 2003
- An evaluation of the number and types of recommendations made by a clinical pharmacologist and pharmacist in an ambulatory consultation service. 2002
- Drug-herb interaction among commonly used conventional medicines: Development of a desk reference for health care professionals. 2002
- Employing a validated assessment tool to evaluate interactions of warfarin with drugs and food. 2002
- Etanercept Community Health Outcomes study (ECHO). 2002
- Pharmacokinetics of melagatran after oral dosing with ximelagatran, a direct thrombin inhibitor, in patients with acute venous thromboembolism (VTE). 2002
- Impairment of pyruvate dehydrogenase activity by acetaldehyde and fetal alcohol syndrome. 2001
- Nebulized isotonic saline: An active placebo in asthma? 2001
- Patient perception of evidence-based therapeutic information guides. 2001
- Patterns of use of natural health products by Ontario seniors. 2001
- Providing evidence-based information to patients: Impact on physician prescribing. 2001
- The use of natural health products (NHP) by Ontario seniors. 2001
- Individualized dosing and side effects of amantadine during influenza A outbreaks in nursing homes. 2000
- Patient and clinician perception of patient medication information needs. 2000
- Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs. 2000
- An evaluation of the quality of herbal remedy information provided by health food store retailers and pharmacists 1999
- Instruments measuring clinical benefit: Who knows best, patient or instrument 1999
- Alendronate co-medications may limit its use. 1998
- Economic evaluation of donepezil (D) for Alzheimer's disease in Canada. 1998
- Intrapatient variability in response to NSAID therapy for rheumatoid arthritis. 1998
- Drug price awareness survey of Ontario physicians. 1996
- Treatment of chronic atrial fibrillation with warfarin or aspirin: A cost-effectiveness and cost-utility analysis. 1996
- A COST-EFFECTIVENESS ANALYSIS OF LOW-MOLECULAR-WIEGHT HEPARIN (LMWH) COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN (H) IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS (PVT) 1995
- DEXTROMETHORPHAN AS AN IN-VIVO PROBE OF TAMOXIFEN N-DEMETHYLATION 1995
- EFFECT OF A POLICY TO REDUCE PHYSICIAN PRESCRIBING OF SUSTAINED-RELEASE (SR) NSAID FORMULATIONS 1995
- EFFECT OF AGING ON VERAPAMIL (VER) N-DEMETHYLATION 1995
- RCT OF POSTMARKETING SURVEILLANCE METHODS 1995
- EVALUATION OF PROGRAMS TO EDUCATE AND INFORM THE ELDERLY IN THE RESPONSIBLE USE OF MEDICATIONS 1993
- THEOPHYLLINE BIOTRANSFORMATION TO A NEW, RIBOSYLATED METABOLITE 1993
- EVALUATING RISK-BENEFIT IN DRUG TRIALS 1992
- HALOTHANE ANESTHESIA AND HEPATIC-INJURY 1992
- THEOPHYLLINE (THEO) BIOTRANSFORMATION BY HUMAN LUNG MICROSOMES 1992
- ADVERSE SYMPTOMS INDEX 1991
- INTERNATIONAL PHARMACEUTICAL SURVEILLANCE - A COMMUNITY-BASED STUDY IN MEXICO 1990
- THE EFFECT OF SUCRALFATE AND FOOD ON IBUPROFEN ENANTIOMER BIOAVAILABILITY 1990
- PHARMACOKINETIC INTERACTION BETWEEN NISOLDIPINE AND PROPRANOLOL 1986
- SUSTAINED THERAPEUTIC ANTICOAGULATION WITH SUBCUTANEOUS HEPARIN FOR THE PRIMARY-TREATMENT OF VENOUS THROMBOSIS 1984
- LONG-TERM TREATMENT OF VENOUS THROMBOSIS WITH LESS INTENSE ANTICOAGULATION 1983
-
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from theCAN‐BIND ‐1 Study. 114:88-117. 2023 - Trends in Postpartum Opioid Prescribing: A Time Series Analysis. 110:1004-1010. 2021
- Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future. 109:867-891. 2021
- Metabolomic and Genome‐wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1. 100:524-536. 2016
- Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma. 99:38-48. 2016
- Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta‐analysis. 98:417-441. 2015
- Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis. 94:367-375. 2013
- A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin. 92:766-770. 2012
- iPSC Technology: Platform for Drug Discovery. 89:639-641. 2011
- New Antithrombotic Drugs. 86:139-146. 2009
- Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis. 77:279-290. 2005
- Quetiapine fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditions. 68:92-97. 2000
- Acetylation phenotype and cytochrome P450IA2 phenotype are unlikely to be associated with peripheral arterial disease. 54:317-322. 1993
- Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers. 51:415-421. 1992
- Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol. 43:39-48. 1988
- Perhexiline during exercise training in coronary heart disease. 34:744-748. 1983
- Commentary. 22:125-130. 1977
- Oral and intravenous propranolol during exercise. 21:700-705. 1977
- Differences between the effects of practolol and propranolol on the diastolic properties of the left ventricle. 21:267-271. 1977